TRIER PHARM ApS: Financial statements 2019
CVR: 31611083
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 527,500 and a net result of DKK -39,600 compared with DKK -21,000 the year before. That is an increase of 12.2% compared with the year before. The profit margin was -7.5%. Equity in the 2019 report amounted to DKK -419,703.
- Revenue
- DKK 527,500
- Gross Profit
- DKK -23,916
- Profit/Loss
- DKK -39,600
- Equity
- DKK -419,703
- Total Assets
- DKK 322,976
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 528 t. | -24 t. | -40 t. | -420 t. | - |
| 2018 | 470 t. | -3 t. | -21 t. | -380 t. | - |
| 2017 | 481 t. | 20 t. | 2 t. | -359 t. | - |
| 2016 | 494 t. | 179 t. | -600 t. | -361 t. | - |
| 2015 | 594 t. | -209 t. | -232 t. | 239 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
TRIER PHARM ApS has published its annual report for 2018. Revenue came to DKK 470,000, and the net result was DKK -21,000.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.